Access to High-Cost Medications After a Cap on Monthly Out-of-Pocket Spending in California

Published in: JAMA Network Open, Volume 4, No. 9 (September 2021). doi: 10.1001/jamanetworkopen.2021.26642

Posted on RAND.org on March 04, 2022

by Erin Audrey Taylor, Christine Buttorff, Vishaal Pegany, Lindsay Petersen, Allison Mangiaracino, Emory Wolf, Lance Lang

High prescription drug costs are a substantial problem for many patients who cannot afford their medications, even with health insurance. Capping monthly out-of-pocket (OOP) costs for high-cost drugs may increase the affordability of these medications. In January 2016, Covered California implemented a monthly cap on OOP costs for high-cost drugs to increase patient access. We evaluated the association of this cap with high-cost drug use and OOP spending.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.